You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天益醫療(301097.SZ):子公司擬收購CRRT-濾器業務相關資產
格隆匯 02-14 18:48

格隆匯2月14日丨天益醫療(301097.SZ)公佈,董事會同意通過新加坡全資子公司PRIMACRONGLOBALPTE.LTD.(潽萊馬克隆國際有限公司,簡稱“潽萊馬克隆”或“買方”)向BELLCOS.R.L.(簡稱“賣方”)收購其CRRT-濾器業務資產。公司擬以現金方式收購賣方的CRRT-濾器業務資產,本次交易對價預計爲1,199萬歐元,資金來源將包括公司自有資金,並可能輔以銀行貸款。爲實現前述交易目的,賣方擬將標的業務資產剝離至其新設的一家全資子公司(簡稱“標的企業”),而後通過新加坡全資子公司潽萊馬克隆收購標的企業100%的股權的方式完成對標的業務的收購。本次交易完成後,公司將通過新加坡子公司潽萊馬克隆持有標的企業100%的股權,標的企業將納入公司合併報表範圍。

本次收購完成後,公司將形成完整的CRRT業務產品線,也將成爲繼費森尤斯,萬益特(原百特腎科業務)之後第三傢俱有CRRT全線產品的公司,構建起能夠獨立和閉環運營的CRRT產品生態圈,對公司的CRRT業務在全球的拓展提供強勁動力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account